Skip to main content
. Author manuscript; available in PMC: 2024 Sep 30.
Published in final edited form as: J Med Chem. 2024 May 24;67(11):9709–9730. doi: 10.1021/acs.jmedchem.4c00856

Table 5.

Broad-Panel Counter Screening of Compound 15b against Other GPCRs, Ion Channels, and Transporters

GPCRs, transporters, ion channels % inhibition (10 μM)a Ki (nM)a GPCRs, transporters, ion channels % inhibition (10 μM) Ki (nM)a
5-HT1A 35.04 ND D1 7.92 ND
5-HT1B 11.55 ND D2 −0.64 ND
5-HT1D 29.09 ND D3 10.45 ND
5-HT1E 18.55 ND D4 20.65 ND
5-HT2A 25.21 ND D5 8.29 ND
5-HT2B 91.67 425.4 ± 81.4 DAT 15.46 ND
5-HT2C 41.39 ND GABAA −17.94 ND
5-HT3 22.6 ND H1 15.7 ND
5-HT5A 20.55 ND H2 25.13 ND
5-HT6 15.34 ND KOR 18.73 ND
5-HT7A 20.68 ND M1 −1.71 ND
α 1A 16.45 ND M2 3.15 ND
α 1B −5.51 ND M3 39.69 ND
α 1D −10.52 ND M4 28.71 ND
α 2A 23 ND M5 −1.37 ND
β 1 10.39 ND MOR 20.45 ND
β 2 −7.69 ND hERG 11.04 ND
a

Values are mean ± SEM of at least three independent experiments.

SEM < 20% where not listed. “ND” means that a Ki binding affinity was not determined because off-target inhibition at 10 μM did not reach 50%.